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Geun-Mook Park1, Jong-Gab Jun2 and Jin-Kyung Kim1*Abstract
Background: XH-14 isolated from Salvia miltiorrhiza is a bioactive component and adenosine antagonist. In the
present study, we evaluated anti-inflammatory properties of XH-14 in murine macrophages.
Methods: RAW 264.7 murine macrophage cell line was cultured with various concentrations of XH-14 in the
absence or presence of lipopolysaccharide (LPS). LPS-induced release and mRNA expression of inflammatory
mediators were examined by ELISA and real-time PCR. The modification of signal pathways involved in
inflammatory reactions was determined by Western blotting analysis.
Results: XH-14 suppressed the generation of nitric oxide (NO) and prostaglandin E2, and the expression of
inducible NO synthase and cyclooxygenase-2 induced by LPS. Similarly, XH-14 inhibited the release of
pro-inflammatory cytokines induced by LPS in RAW 264.7 cells. The underlying mechanism of XH-14 on
anti-inflammatory action was correlated with down-regulation of mitogen-activated protein kinase and activator
protein-1 activation.
Conclusions: XH-14 inhibits the production of several inflammatory mediators and so might be useful for the
treatment of various inflammatory diseases.
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Inflammation is a basic way in which the body reacts to
infection, irritation or other injury, the key feature being
redness, warmth, swelling and pain. An inflammatory re-
action directs immune system components to the site of
injury or infection, and is manifest by increased blood sup-
ply and vascular permeability, which allows chemotactic
peptides, neutrophils and mononuclear cells to leave the
intravascular compartment [1,2]. When an inflammatory
reaction is uncontrolled and prolonged, the pathogenesis
of chronic diseases such as cancer, arthritis, autoimmune
disorder and vascular disease occurs [3]. Because of these
reasons, various efforts to regulate inflammatory reactions
have been carried, one being to discover dietary phyto-
chemicals capable of suppressing inflammation [4,5].* Correspondence: toto0818@cu.ac.kr
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reproduction in any medium, provided the orVarious infecting agents, such as bacteria and pro-
inflammatory cytokines, can activate macrophages, which
are critical immune cells to regulate innate immunity,
through certain receptors. The interaction of Toll like
receptor (TLR)-4 with the ligand, lipopolysaccharide
(LPS), induces an intracellular signaling cascade that
activates the mitogen-activated protein kinase (MAPK)
family, extracellular signal-related kinase (ERK), p38,
C-jun N-terminal kinase (JNK) and adaptor molecules,
and ends in the activation of key pro-inflammatory tran-
scription factors such as activator protein (AP)-1 and
nuclear factor-kappa B (NF-κB) [6,7]. Eventually, these
signaling events lead macrophages to be transcription-
ally activated for expressing pro-inflammatory genes includ-
ing, inducible nitric oxide synthase (iNOS), cyclooxygenase
(COX)-2 and various cytokines [7,8].
XH-14 is a bioactive component isolated from Salvia
miltiorrhiza, also known as Danshen. Danshen is pur-. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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traditional Chinese medicine [9,10]. XH-14 binds the A1
adenosine receptor with relatively high affinity [10] and
XH-14 and their derivatives can inhibit adipocyte differ-
entiation and induction of the adipokines, visfatin and
resistin, in 3T3-L1 adipocytes [11]. Although XH-14 has
potent biological and physiological functions, the involve-
ment in regulation of inflammatory reactions remains
unknown. In this study, we aimed to investigate thera-
peutic potential of its medicinal benefits against numerous
inflammatory diseases by employing in vitro inflammatory
conditions. In particular, because no study has reported
the exact molecular target for the anti-inflammatory
effects of XH-14, we focused on finding the inhibitory
targets of XH-14.Methods
Chemicals and reagents
XH-14 was synthesized by using a Sonogashira reaction
as previously reported [9,12]. LPS derived from Escheri-
chia coli and dimethylsulfoxide (DMSO) were obtained
from Sigma-Aldrich (St Louis, MO, USA). Dulbecco’s
modified Eagle’s medium (DMEM), fetal bovine serum
(FBS), penicillin and streptomycin were obtained from
Hyclone (Logan, UT, USA). The final concentrations of
DMSO never exceeded 0.1%, which did not affect the
assay systems. The antibodies (Abs) used were: anti-
iNOS rabbit polyclonal, anti-COX-2 monoclonal Ab
(mAb), anti-inhibitor of NF-κB (IκBα) mAb, anti-phos-
pho-c-Jun, anti-C-Jun, anti-phospho-c-Fos, anti-c-Fos,
anti-phospho-JNK rabbit polyclonal, anti-ERK1/2 rabbit
polyclonal, anti-phospho-p38 rabbit polyclonal, anti-p38
rabbit polyclonal, (Cell Signaling Technology, Danvers,
MA, USA) and anti-β-actin mAb (Sigma-Aldrich).Cell culture and cell viability assay
RAW 264.7 murine macrophages obtained from the
Korean Cell Bank (Seoul, Korea) were cultured in DMEM
containing 10% FBS, 100 U/ml penicillin and 100 μg/ml
streptomycin at 37°C in 5% CO2. The effects of XH-14
on cell viability were tested using the CellTiter 96W
AQueous One Solution Assay of cell proliferation (Promega,
Madison, WI, USA). RAW 264.7 cells were plated at a
density of 2 × 104 cells in a 96-well flat-bottom plate, and
XH-14 were added to each plate at indicated concentra-
tions. After a 24 h incubation period, the number of viable
cells was counted according to the manufacturer's instruc-
tions. This assay is based on the reduction of a tetrazolium
compound, MTS, to formazan, which has an optimum
absorption at 490 nm. Thus, the quantity of the product in
the cell culture is indicated by the optical density of forma-
zan at 490 nm, which is directly proportional to the num-
ber of living cells.Measurement of nitrite, prostaglandin E2 (PGE2) and
cytokines
The amount of nitrite, PGE2 interleukin (IL)-1β and IL-6
produced by the mouse macrophages was measured in
RAW 264.7 cell culture supernatant. RAW 264.7 cells
were plated at a density of 2.5 × 105 cells in a 48-well
cell culture plate with 500 μl of culture medium and
incubated for 12 h. They were then treated with indi-
cated concentrations of XH-14 plus LPS (100 ng/ml)
and incubated for another 24 h. The amount of nitrite
and PGE2 produced was measured using the Griess
reagent system (Promega) and an enzyme-linked im-
munosorbent assay (ELISA) kit (ENZO Life Sciences,
Farmingdale, NY, USA) according to the manufacturer’s
instruction, respectively. IL-1β and IL-6 were measured
using an ELISA kit (eBioscience, San Diego, CA, USA)
according to the manufacturer’s instructions.
Quantitative real-time reverse-transcription polymerase
chain reaction (RT-PCR)
Total RNA was isolated from RAW 264.7 cells and
reverse-transcribed into cDNA using TriZol Reagent
(Invitrogen, Carlsbad, CA, USA) and CCC TAC CAA
GT-3’, R 5’- CAC CCA AAG TGC TTC AGT CA-3’;
murine COX-2: F 5’-AAG ACT TGC CAG GCT GAA
CT-3’, R 5’-CTT CTG CAG TCC AGG TTC AA -3’;
murine IL-1β: F 5’-TTC TCC ACA GCC ACA ATG
AG-3’, R 5’-ACG GAC CCC AAA AGA TGA AG-3;
murine IL-6: F 5’-CAT CCA GTT GCC TTC TTG
GGA-3’, R 5’- CCA GTT TGG TAG CAT CCA TC -3’;
GAPDH: F 5’-TCT TGC TCA GTG TCC TTG C-3’, R
5’-CTT TGT CAA GCT CAT TTC CTG G-3’. Real-
time PCR assay was carried out with LightCycler (Roche
Diagnostics, Germany) using LightCycler FastStart DNA
Master SYBR Green I (Roche Diagnostics). Transcripts of
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), as
a housekeeping gene, were quantified as endogenous RNA
of reference to normalize each sample. Relative quantities
were estimated by the delta-delta-Ct method. The results
were normalized as relative expression in which the aver-
age value of the iNOS, COX-2, IL-1β and IL-6 mRNA was
divided by the average value of GAPDH mRNA.
Western blotting analysis
Whole cell extracts, cytoplasmic and nuclear proteins
(30 μg protein/lane) were separated by 10% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). The separated proteins were electrophoretically
transferred onto nitrocellulose membranes. Immunor-
eactive bands were detected by incubating the samples
with horseradish peroxidase (HRP)-conjugated second-
ary antibodies and visualized using a WEST-ZOL plus
Western Blot Detection System (iNtRON Biotechnology,
Seongnam-Si, Korea).
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The data are depicted as the mean ± SEM. Student t-test
was performed using the GraphPad Prism 4.0 software
(GraphPad Software, San Diego, CA, USA) and P < 0.05
was considered as statistically significant.
Results
Effects of XH-14 on the release of NO and PGE2
To evaluate XH-14-induced anti-inflammatory effects,
we used an in vitro model with the murine RAW 264.7
macrophage cell line. Since XH-14 showed no cytotox-
icity with concentrations up to 20 μM in RAW 264.7
macrophages (Figure 1B), we used up to 20 μM XH-14
for the rest of the experiments. We first sought to deter-
mine the effect of XH-14 on the LPS-induced release
of the inflammatory mediators, NO and PGE2, by
RAW 264.7 cells. As shown in Figures 2A and 2B, XH-14
inhibited LPS-induced NO and PGE2 production in a
dose-dependent manner. The nitrite concentrations in
LPS-stimulated cells and in those exposed to 20 μM
XH-14 were 18.22 ± 0.74 μM and 5.27 ± 0.22 μM,
respectively. The inhibitory effects of XH-14 on PGE2
production in LPS-exposed cells were similar to their
effects on NO production (Figure 2B). To determineFigure 1 Effects of XH-14 on murine macrophage viability. (A)
Chemical structure of XH-14. (B) RAW 264.7 cells were treated with
indicated concentrations of XH-14 for 24 h, and proliferation was
determined. The results are reported as mean ± SEM of three
independent experiments in triplicate.the mechanism by which XH-14 reduces LPS-induced
NO and PGE2 production, we studied the effect of
XH-14 on iNOS and COX-2 protein expression in
RAW 264.7 cells using Western blot analysis, since those
enzymes catalyze the reaction for NO and PGE2, respect-
ively. Consistent with the findings related to NO produc-
tion, the protein expression of iNOS induced by LPS in
RAW 264.7 cells was also reduced by XH-14 treatment
(Figure 2C), while having only a marginal effect on COX-2
protein expression.
XH-14 inhibits the release of pro-inflammatory cytokines
in murine macrophages
We next examined if XH-14 reduced the release of pro-
inflammatory cytokines in LPS-stimulated RAW 264.7
cells. Although the concentrations of IL-1β and IL-6
were not detected in vehicle-treated RAW 264.7 cells,
LPS treatment elevated the levels of IL-1β (57.44 ± 4.33
pg/ml) and IL-6 (2842 ± 47.53 pg/ml) in LPS-treated
RAW 264.7 cells. XH-14 induced marked suppression of
increases induced by LPS in these cytokines (Figure 3).
LPS-treated RAW 264.7 cells exposed to XH-14 at con-
centrations of 1, 5 and 20 μM displayed a dose-
dependent inhibited production of IL-1β (10, 16 and
44%, respectively) and IL-6 production (29, 47 and 81%,
respectively). These results indicate that XH-14 sup-
pressed various inflammatory mediators including NO
and PGE2, as well as pro-inflammatory cytokines, such
as IL-1β and IL-6.
XH-14 inhibits the mRNA expression of iNOS, COX-2, IL-1β
and IL-6 in murine macrophages
Since XH-14 suppressed the protein levels of iNOS,
COX-2 and pro-inflammatory cytokines in LPS-
stimulated RAW 264.7 cells, quantitative real time PCR
was used to assess the effects of XH-14 on LPS-induced
gene expression of iNOS, COX-2, IL-1β and IL-6 in
RAW 264.7 cells. Upon LPS treatment, the mRNA
expressions of these four genes were markedly augmen-
ted. The concentration response for inhibition of iNOS,
COX-2, IL-1β and IL-6 mRNA expressions is shown in
Table 1. The results showed that the effect of XH-14 on
mRNA expression of iNOS and COX-2 as well as IL-1β
and IL-6 was coincidence with the protein expression
and secretion of that in supernatants, respectively.
XH-14-reduced inflammatory mediator release is
associated with inhibition of MAPK and AP-1 in murine
macrophages
Since NF-κB signals regulate the transcription of various
genes, including inflammatory mediators, RAW 264.7
macrophages were treated with LPS in the presence or
absence of XH-14 and the degradation of Iκ-Bα, an im-
portant biochemical event for the nuclear translocation
Figure 2 Effects of XH-14 on LPS-induced NO and PGE2 release. RAW 264.7 cells were treated with 0–20 μM of XH-14 in the presence of
100 ng/ml of LPS or with LPS alone for 24 h, and (A) NO and (B) PGE2 release was determined. The results are reported as mean ± SEM of three
independent experiments in triplicate. Statistical significance is based on the difference when compared with LPS-stimulated cells (*P < 0.05,
**P < 0.01, ***P < 0.001). Thirty micrograms of protein obtained from each cell lysate was resolved by 10% SDS-PAGE for (C) iNOS and (D) COX-2
determination. β-actin expression is shown as a loading control. The bands were quantified using NIH image analysis software and their relative
intensity was expressed as fold against the image of the LPS-stimulated RAW 264.7 cells.
Park et al. Journal of Inflammation 2013, 10:1 Page 4 of 7
http://www.journal-inflammation.com/content/10/1/1of NF-κB, was determined. As shown in Figure 4A, XH-14
treatment had no effect of the degradation of Iκ-Bα
induced by LPS stimulation. In addition to NF-κB,
MAPKs pathways are also involved in the regulation of
pro-inflammatory mediator expression [13,14]. Treatment
with LPS for 30 min resulted in a significant increase in
the phosphorylation of JNK, p38 and ERK compared to
the vehicle-treated group (Figure 4A). XH-14 markedly
prevented LPS-induced increase of JNK and ERK phos-
phorylation in a concentration-dependent manner, but not
phosphorylation of p38 (Figure 4A).
AP-1 is a heterodimeric protein that comprises pro-
teins from various families, including c-Jun and c-FosFigure 3 Effects of XH-14 on LPS-induced inflammatory cytokine prod
0–20 μM of XH-14 in the presence of 100 ng/ml LPS or with LPS alone for
(Α) IL-1β and (B) IL-6 released was measured. The results are reported as m
significance is based on the difference when compared with LPS-stimulate[15,16]. Because the expression of AP-1 is under the
regulation of the crucial upstream regulatory pathway
MAPKs [15-17], we determined the nuclear transloca-
tion of c-Jun and c-Fos. As shown in Figure 4B and C,
XH-14 inhibited the nuclear translocation of c-Fos and
c-Jun induced by LPS stimulation.
Discussion
XH-14 is one of the natural products isolated from
Danshen and is the first-known nitrogen free adenosine re-
ceptor ligand. XH-14 is a characteristic member of the
neolignan family. Neolignans are widespread in nature.
They have a wide variety of chemical structures and exhibituction in murine macrophages. RAW 264.7 cells were treated with
24 h. The cell culture media were then collected, and the amount of
ean ± SEM of three independent experiments in triplicate. Statistical
d cells (*P < 0.05, ***P < 0.001).
Table 1 Effects of XH-14 on LPS-induced mRNA expression of iNOS, COX-2, IL-1β and IL-6 in RAW 264.7 cells1
mRNA iNOS COX-2 IL-1β IL-6
(relative expression)
vehicle NDa ND ND ND
LPS 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00
LPS + 1 μM XH-14 1.14 ± 0.21 0.80 ± 0.23 0.90 ± 0.02 0.74 ± 0.27
LPS + 5 μM XH-14 0.79 ± 0.12** 0.69 ± 0.25 0.45 ± 0.06*** 0.75 ± 0.11**
LPS + 20 μM XH-14 0.65 ± 0.03*** 0.71 ± 0.01*** 0.37 ± 0.03*** 0.59 ± 0.05***
1LPS-stimulated RAW 264.7 cells were cultured with 0–20 μM XH-14 in the presence or absence for 6 h and gene expression was quantified by real-time RT-PCR.
The results are reported as mean ± SEM of three independent experiments in triplicate. Statistical significance is based on the difference when compared with
LPS-stimulated cells (**P < 0.01, ***P < 0.001).
a ND; Not detected.
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[18], anti-proliferative [19], anti-viral [20] and immunosup-
pressive [21]. Since initial reports that focused on the isola-
tion and synthesis of XH-14, the compound’s biological
and physiological activities have remained elusive. Only
one study to date has demonstrated a biological function
of XH-14, namely the suppressed differentiation of 3T3-L1
adipocytes through the reduction of cellular levels of prolif-
erator activated receptor-γ and CCAAT enhancer binding
protein-α [11]. The present study investigated the effect of
XH-14 on inflammation.Figure 4 Effect of XH-14 on LPS-induced MAPK and AP-1 activation. R
12 h of seeding, cells were treated with different doses of XH-14 for 1 h, fo
cell extracts, (B) cytosolic proteins and (C) nuclear proteins were immunob
were used as a control. The bands were quantified using NIH image analys
against the image of the LPS-stimulated RAW 264.7 cells.XH-14 significantly decreased the production of NO,
PGE2 and pro-inflammatory cytokines in LPS-stimulated
murine macrophages. The inhibition of NO was due to
the inhibition of iNOS expression at protein and mRNA
levels. PGE2 was considered one of the strongest inflam-
matory mediators in inflammatory response. It was trans-
formed from arachidonic acid via the COX-2 catalytic
reaction. Although the levels of PGE2 and COX-2 mRNA
significantly decreased in XH-14 treated RAW 264.7 cells,
the expression of COX-2 protein showed anechoic re-
sponse by XH-14 treatment. The results suggested thatAW 264.7 cells were plated in 100 mm-diameter dishes. After
llowed by stimulation with 100 ng/ml of LPS for 30 min. (A) Whole
lotted with the indicated Abs. β-actin and poly ADP ribose polymerase
is software and their relative intensity was expressed as fold-change
Park et al. Journal of Inflammation 2013, 10:1 Page 6 of 7
http://www.journal-inflammation.com/content/10/1/1the XH-14 might be attributed to its inhibitive effect on
PGE2 production through blocking COX-2 gene expres-
sion as well as activity of COX-2 but not protein
expression.
Inflammatory enzymes, iNOS and COX-2, can be used
as therapeutic targets to treat various inflammatory dis-
eases. Indeed, non-steroidal anti-inflammatory drugs
that suppress COX activities have been used clinically
for the treatment of fever, inflammation and pain [22].
In addition, the presence of iNOS in macrophages is sig-
nificant and, once present, iNOS synthesizes 100–1000
times more NO than the constitutive enzymes and does
so for prolonged periods. Since the excessive production
of NO and resulting NO-derived metabolites elicit cellu-
lar toxicity and tissue damage, which contribute to the
pathophysiology of a number of diseases, disorders and
conditions, iNOS inhibitors have been investigated for
the treatment of iNOS-mediated diseases and conditions
including pain, hypotension, inflammation, arthritis and
asthma [23]. Based on these facts, XH-14 could be a pos-
sible candidate for the treatment of various inflammatory
diseases by inhibiting the release of NO and PGE2.
The present results provide some preliminary but use-
ful insights into the molecular mechanisms of XH-14.
XH-14 did not affect the degradation of Iκ-B, but sup-
pressed the phosphorylation of ERK and JNK as well as
nuclear translocation of AP-1, c-fos and c-jun, which
were induced by LPS stimulation. To the end of the sig-
naling generated by LPS in macrophages, the activation
of transcription factors results in the production of both
pro- and anti-inflammatory mediators. The binding of
LPS to TLR-4 leads to activation of transcription factor
NF-κB and AP-1, which regulate innate immune
responses [24]. Activation of NF-κB and AP-1 induces
the expression of several inflammatory mediators such
as iNOS, COX-2, IL-1β and IL-6, along with many other
genes [25,26]. The degradation and phosphorylation of
Iκ-B are necessary to release NF-κB from the cytoplas-
mic NF-κB/IκB complex and allow its subsequent trans-
location to the cell nucleus. AP-1 is composed of
proteins belonging to the Jun and Fos families, and c-jun
and c-fos are immediate-early genes [27]. MAPK signal-
ing pathways regulate AP-1 activity by increasing tran-
scription and by the phosphorylation of AP-1 proteins.
These results suggest that the inhibition of NO, PGE2 and
pro-inflammatory cytokines in XH-14 treated RAW 264.7
cells is associated with the down-regulation of AP-1
transcription factors through the inhibition of the MAPK
signaling pathway.
Conclusion
As part of our studies on bioactive constituents from
natural products, we previously reported various inhibi-
tors of the release of various inflammatory mediatorsinduced by LPS [28-30]. The present results demonstrate
that XH-14 significantly inhibits LPS-induced release of
NO, PGE2, IL-1β and IL-6, as well as mRNA levels of
iNOS, COX-2, IL-1β and IL-6 in RAW 264.7 cells. The
same phenomenon was manifested by the inhibitory
effects on phosphorylation of ERK and JNK followed by
nuclear translocation of AP-1. On the other hand, its
inhibitory effects were not shown in Iκ−Bα degradation.
A further challenge is to delineate in vivo actions of
XH-14 to provide a better understanding of the health-
promoting effects of a phytochemical that is widely con-
sumed globally.
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